-
公开(公告)号:EP3303286A1
公开(公告)日:2018-04-11
申请号:EP16804352.9
申请日:2016-06-01
IPC分类号: C07C315/00 , C07C317/00 , C07C317/14
CPC分类号: A61K31/4174 , A61K31/04 , A61K31/10 , A61K31/403 , A61K31/4164 , A61K31/428 , A61K31/445 , A61K31/495 , A61K31/5375
摘要: The invention provides methods and agents that modulate RelA activity. These methods and modulators of RelA activity can be used to treat cancer progression of basal-like breast cancer, such as triple-negative breast cancer.